MedTrace Logo

Patch Test of Benzalkonium Chloride Disinfectant Spray

NCT01762982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-01-22

Study results available
· View outcomes & findings →

Summary

The aim of the study is to evaluate the irritation potential of benzalkonium chloride disinfectant spray when placed in contact with normal human skin.

Conditions

  • Wound Healing

Interventions

DRUG

0.13% Benzalkonium Chloride

Finn Chamber filled with benzalkonium chloride (0.13%) disinfectant spray water solution

DRUG

SLS Solution

Finn Chamber filled with SLS (0.3% w/v) water solution

DRUG

Normal Saline Water

Finn Chamber filled with Normal Saline water (0.9% w/v)

OTHER

Empty Finn Chamber

Empty Finn Chamber

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01762982 on ClinicalTrials.gov